Laboratory studies demonstrate that FOXO4-DRI can eliminate chemotherapy-induced senescent cells that may contribute to administration resistance, while the timing of senolytic administration relative to chemotherapy requires careful optimization in experimental designs
Adding too much or too little solvent can affect the stability and makes accurate dosing impossible
Pregnancy and Breastfeeding Theres some controversy about whether pregnant and breastfeeding women can maintain a healthy B12 status for themselves, their fetuses, or their infants without a daily B12 intake
There is preclinical and animal data along with methodologically flawed studies
The study also noted reduced liver fat, as measured by the controlled attenuation parameter (CAP), pointing to a potential reduction in steatosis severity
You have to know that if I haven't tried it, I wouldn't (in any way) recommend it